For inquiries about any news items, email: email@example.com
ML161 (aka Parmodulin 2) greatly improves kidney function in a mouse model of diabetic kidney disease
Paul Ornstein, Ph.D. joins as VP of Preclinical Development
Function Therapeutics receives Dept. of Defense award.
U.S. patent #11,130,743 has been granted.
Function Therapeutics, Inc. has incorporated.
Function Therapeutics announces initial Scientific Advisory Board members.